app_store_button

google_play_button

DK - Details page - Device banner - 894x1036

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

Lyt når som helst, hvor som helst 

Bloomberg

Money goes where it’s treated best. That simple truth is a big reason why more and more money (trillions, in fact) flows into a powerful, low-cost tool that’s quietly transformed investing. Exchange-traded funds let you invest in everything from the stock market to gold like never before. This biweekly podcast will demystify them—and hopefully delight you in the process.

Trillions

To kick off the new year, Bloomberg Intelligence has its annual list of ETFs for your stocking-shaped portfolio. While these aren't buy or sell market predictions, the funds are worthy of your watchlist as they may help investors tap into or navigate important themes. And you never know, a few of them could even have a breakout moment you'll find yourself humble-bragging about.
 
On this episode of Trillions, Eric Balchunas and Joel Weber are joined by Bloomberg Intelligence analysts Athanasios Psarofagis and James Seyffart, who helped write the team's annual report. The episode features 16 ETFs, including the tickers BINC, XOVR, MSOS, BUFB, UFOD, OTGL, VXUS, SBIL, RSST, SPYM, BOXX, GRFT, ITB, PXUI, PCLN and LRND.

See omnystudio.com/listener for privacy information.

ETFs to Watch in 2026

Competing in the marketplace for exchange-traded funds — aka "The Terrordome" — is not for the faint of heart. It's like fighting a multi-front war where issuers have to market existing funds; engage in fee wars with the likes of Vanguard and BlackRock; and innovate in a rapidly changing industry, which now includes more than 300 firms. Only the strong thrive.
 
On this episode of Trillions, Eric Balchunas and Joel Weber speak with Brian Hartigan, the global head of ETFs and index investments at Invesco. The fourth-biggest ETF issuer in the US, Invesco has about $800 billion in assets under management and saw inflows of $67 billion in 2025. They discuss how the company competes against the industry's "Big Three," the secret behind QQQ's dramatic success and the surprising staying power of smart-beta ETFs. They also explore whether there are simply too many ETFs and how retail investors should assess volatile assets, like Bitcoin.

See omnystudio.com/listener for privacy information.

Invesco's ETF Playbook

2025 is arguably the single best year in ETF history as the industry has broken all-time records in the three primary categories: flows, launches and volume. What is behind these numbers and how long can these good times last? 

On this episode of Trillions, Joel and Eric look at the year that was with Katie Greifeld, reporter and anchor at Bloomberg News and Todd Sohn, senior ETF technical strategist at Strategas Securities. The conversation also includes the boon in leveraged ETFs, option-based funds, industry consolidation and whether small caps or low volatility can ever mount a comeback.

See omnystudio.com/listener for privacy information.

ETFs Win Triple Crown in 2025

So far this year, some 920 exchange-traded funds have launched in the US alone—a new record. Some are already juggernauts. Others are more about capturing vibes than assets. And then there are some intriguing sleepers that remain under the radar. So, which is the best new addition to the overall investing landscape?
 
On this episode of Trillions, Eric Balchunas and Joel Weber welcome colleagues from Bloomberg News and Bloomberg Intelligence — Isabelle Lee, Denitsa Tsekova, Andre Yapp, Vildana Hajric, James Seyffart and Athanasios Psarofagis — to make their cases for the best new ETF of 2025. Executive Editor David Papadopolous returns to Trillions as a highly subjective judge with questionable methodology. Tickers mentioned in this episode include $MEME, $CAIE, $HUMN, $TEXN, $XDIV, $BSOL, $VBIL and $GXLC.

See omnystudio.com/listener for privacy information.

The Best ETF Launch of 2025

You may not know the term autocallable, but you will. There’s a new type of high income ETF that tracks autocallable notes that yield 14% a year and is having instant success with flows coming in every single week since it launched in June. It’s all part of the boom in ETFs using derivatives (instead of stocks or bonds) to generate income streams. 
 
On this episode of Trillions Joel and Eric speak with Matt Kaufman, head of ETFs at Calamos Investments, about how autocallables work and the risks and rewards of investing in ETFs that track them. 

See omnystudio.com/listener for privacy information.

Autocallable ETFs

The election of Sanae Takaichi as Japan’s first woman prime minister is putting a new spotlight on the country. Markets expect the “Iron Lady,” as she’s known, to continue some of the policies of Shinzo Abe, under whom the yen weakened while equities rocketed.
 
On this episode of Trillions, Eric Balchunas and Joel Weber speak with Jeremy Schwartz, chief investment officer at WisdomTree. They discuss the stellar performance of his flagship Japan Hedge Equity Fund, how Warren Buffett capitalized on Japan’s opportunities, why the country’s high debt-to-GDP ratio matters, what investors can expect from the new prime minister—and more.

See omnystudio.com/listener for privacy information.

Is Japan Back?

With so many assets at or near all-time highs, a rational investor might wonder how long can the good times last? And is now the time to consider an insurance policy for the inevitable pullback? And also, what sort of downside protection should you use, if any?
 
On this episode of Trillions, Eric Balchunas and Joel Weber speak with Bloomberg reporters Bernard Goyder and Suzanne Woolley about the spectrum of hedging strategies, many of which now involve exchange-traded funds. At one end are advanced approaches that involve the volatility index, or VIX, which can have big payoffs while also being as dangerous as juggling chainsaws. They also discuss more vanilla options such as Treasuries and gold, as well as buffer ETFs—aka “boomer candy.” 

See omnystudio.com/listener for privacy information.

Protecting Your Portfolio With ETFs

The “American dream” has always been about money: financial progression and building wealth. But for many the concept is slipping further and further away as the country’s yawning wealth gap widens. So the question is: can you still climb the proverbial wealth ladder, or is the dream dead? And if there is still room to rise, how important is salary versus investments? How can exchange-traded funds help?
 
On this episode, Joe and Eric speak with Nick Maggiulli, author of the new book, The Wealth Ladder: Proven Strategies for Every Step of Your Financial Life, and chief operating officer and data scientist at Ritholtz Wealth Management. Topics discussed include how the ladder breaks, pros and cons of different strategies for climbing it and how intertwined happiness and wealth are.

See omnystudio.com/listener for privacy information.

Climbing the Wealth Ladder with Nick Maggiulli

Young people are looking for an easier way to accumulate wealth than working a 9-5 job for 40 years. This reluctance to follow the path of their elders has grown the appeal—and assets—of income-generating exchange-traded funds, which can generate anywhere between 2% and 200% yields, sometimes using complex derivatives.
 
This universe of ETFs has exploded in popularity, with the assets ballooning to $750 billion. And while regular payouts may sound alluring, investors might be prioritizing short-term action over long-term gains.
 
On this episode of Trillions, Eric Balchunas and Joel Weber speak with Vildana Hajric, a cross-asset reporter with Bloomberg News, about how these income ETFs work, why they appeal to young investors and what to know about their risks.

See omnystudio.com/listener for privacy information.

Dividends Over Day Jobs: Income ETFs Become Huge Hit with Gen Z

A relentless barrage of headlines in recent weeks have all centered on exchange-traded funds. For the first time, there are now more ETFs than stocks (4,300 versus 4,200). Also of note, ETFs have also become prized listings for exchanges—perhaps even more than IPOs—because they trade so much.
 
On this episode of Trillions, Eric Balchunas and Joel Weber speak with Dave Nadig, president and director of research at ETF.com, and Athanasios Psarofagis, an analyst with Bloomberg Intelligence. They discuss those stories as well those on passive ownership's increasing complexity; a different way to think about the Magnificent Seven; Vanguard's push into active management; Wall Street not seeing a need for tokenization; and the irony of European ESG equity funds having exposure to the nuclear arms industry.

See omnystudio.com/listener for privacy information.

Tour de Headlines: A Roundtable About Recent ETF Stories of Note

While much of the stock market has suffered over the past few weeks thanks to fear of the new coronavirus and its global economic fallout, there are a handful of stocks and exchange traded-funds that have managed to avoid damage, and even flourish.

On this coronavirus-themed episode of Trillions, Bloomberg Intelligence Senior ETF Analyst Eric Balchunas and Bloomberg Businessweek Editor Joel Weber dive into the world of niche biotech ETFs.

Joining them are Paul Yook and Ryan Cinalli of LifeSci Index Partners, who have launched Virtus LifeSci Biotech Product ETF and Virtus LifeSci Biotech Clinical Trials ETF, and are currently working on a third.

See omnystudio.com/listener for privacy information.

Biotech ETFs Vs. The Coronavirus

Lyt når som helst, hvor som helst

Other podcasts you might like ...